| Financial Year |
March 31 2023 |
| Monetary Funds |
2,718,097,342.75 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
224,049,531.88 |
| Accounts Receivable |
3,005,281,380.37 |
| Advances to Suppliers |
300,814,786.53 |
| Other Receivables |
84,059,234.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,631,961,800.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
252,286,454.61 |
| Total Current Assets |
8,216,550,531.01 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
53,794,965.00 |
| Long-term Equity Investment |
951,554,936.02 |
| Investment Properties |
-- |
| Fixed Assetes |
3,545,614,806.50 |
| Under-construction Projects |
883,478,017.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
977,756,983.49 |
| R&D expenses |
136,382,528.52 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
214,333,783.15 |
| Deferred Income Tax Assets |
124,986,979.53 |
| Other Non-Current Assets |
348,036,631.21 |
| Sub-Total of Non-Current Assets |
7,345,094,160.65 |
| Total Assets |
15,561,644,691.66 |
| Short-Term Loans |
3,940,228,548.78 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,280,784,926.37 |
| Accounts Payable |
1,112,435,448.30 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
743,327.56 |
| Taxes Payable |
30,395,630.10 |
| Interest Payable |
-- |
| Dividend Payable |
321,132.31 |
| Other payables |
174,489,267.21 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,075,044,853.59 |
| Other Current Liabilities |
594,690,171.58 |
| Sub-Total of Current Liabilities |
8,216,969,539.52 |
| Long-term Loans |
1,208,996,944.44 |
| Bonds Payable |
275,244,112.01 |
| Long-Term Accounts Payable |
1,180,345,866.73 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
101,274,940.44 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,929,175,417.27 |
| Total Liabilities |
11,146,144,956.79 |
| Paid-In Capital(Or Share Stock) |
1,073,597,165.00 |
| Capital Surplus |
1,305,769,410.90 |
| Surplus Reserve |
148,566,761.53 |
| LESS:Treasury Stock |
161,977,310.00 |
| Undistributed Profits |
1,234,927,626.92 |
| Minority Stockholder's Interest |
789,808,294.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,625,691,440.66 |
| Owner's Equity（Stockholder's Equity） |
4,415,499,734.87 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,561,644,691.66 |
